Exicure, Inc. Announces Appointment of New CEO and CFO and Changes to Board of Directors

Exicure, Inc. , historically an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets, today announced that, effective as...

Related Keywords

Jiyoung Hwang ,Hojoon Lee ,Paul Kang ,Dongho Lee ,Michael Kim ,Hyuk Joon Raymond Ko ,Changil Ahn ,Exicure Inc ,Exchange Commission On ,Company Annual Report On Form ,Exchange Commission ,Nasdaq ,Chief Executive Officer ,Chief Financial Officer ,Hyuk Joon ,Private Securities Litigation Reform Act ,Annual Report ,Markets ,